NEW BIO & Tech SRL
NEW BIO & Tech reported total assets of 3,186 € at the end of the 2022 financial year (annual accounts filed with the NBB on 13 Jun 2023).
The score of NEW BIO & Tech shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2022
Change 2019 → 2022: Equity -30 % Total assets -30 %
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
NEW BIO & Tech's annual accounts
Filed annual accounts
- Year ended 31 Dec 2022filed on 13 Jun 2023
- Year ended 31 Dec 2019filed on 12 Jan 2021
NEW BIO & Tech's financial analysis
- Solvency100.0%sector median: 27.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of NEW BIO & Tech
NEW BIO & Tech's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0726.931.757
- VAT number
- BE0726931757
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SRL
- Incorporated
- 20 May 2019
- Registered office
- 1060 Saint-Gilles
- Latest accounts
- 2022 · filed on 13 Jun 2023
- Activity
- Non-specialised retail sale of predominately food, beverages or tobacco (NACE 47110)
NEW BIO & Tech (SRL) has been based in Saint-Gilles since 2019, active in: non-specialised retail sale of predominately food, beverages or tobacco. For 2022, it reports a net loss of 593 € and equity of 3,186 €; its revenue is not published. Its solvency stands at 100.0%, above the median of its sector (27.6%).
Companies similar to NEW BIO & Tech
Companies in the same business, of comparable size and area, outside its group.
- Ring WAY Non-specialised retail sale of predominately food, beverages or tobacco Anderlecht · balance sheet 7,228 €
- Shine Ronny Non-specialised retail sale of predominately food, beverages or tobacco Saint-Gilles · balance sheet 17,331 €
- Elma 24 Non-specialised retail sale of predominately food, beverages or tobacco Brussels · balance sheet 44,390 €
- Darklights Non-specialised retail sale of predominately food, beverages or tobacco Saint-Gilles · balance sheet 40,270 €
- T-Series Business Non-specialised retail sale of predominately food, beverages or tobacco Anderlecht · balance sheet 34,597 €
- Thorrez-Hauspie Non-specialised retail sale of predominately food, beverages or tobacco Torhout · balance sheet 2,091 €
- Nancy Trading Non-specialised retail sale of predominately food, beverages or tobacco Forest · balance sheet 48,198 €
- S.H.D.D. Non-specialised retail sale of predominately food, beverages or tobacco Montigny-le-Tilleul · balance sheet 54,151 €
Frequently asked questions about NEW BIO & Tech
What is the revenue of NEW BIO & Tech?
NEW BIO & Tech files its accounts in a format where revenue is optional: it is not published for 2022.
What is the VAT number of NEW BIO & Tech?
In Belgium, the VAT number is the company number prefixed with BE: BE0726931757 for NEW BIO & Tech, if the company is VAT-registered. Its company number (CBE) is 0726.931.757.
Where is the registered office of NEW BIO & Tech?
According to the CBE register, the registered office of NEW BIO & Tech is in 1060 Saint-Gilles.
What is the equity of NEW BIO & Tech?
At the close of the 2022 financial year, the equity of NEW BIO & Tech amounts to 3,186 €, a solvency of 100.0% of total assets.
Who manages NEW BIO & Tech?
The register lists 2 active mandates at NEW BIO & Tech. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of NEW BIO & Tech
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →